Deciding about prophylactic oophorectomy: What is important to women at increased risk of ovarian cancer?

被引:33
作者
Fry, A
Rush, R
Busby-Earle, C
Cull, A
机构
[1] Western Gen Hosp, Imperial Canc Res Fund, Med Oncol Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Univ Edinburgh, Dept Obstet & Gynaecol, Edinburgh EH8 9YL, Midlothian, Scotland
关键词
ovarian cancer; prophylactic oophorectomy; decision-making; cancer worry;
D O I
10.1006/pmed.2001.0924
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Little is known about the factors that women at increased risk of ovarian cancer consider to be important when deciding about prophylactic oophorectomy, surgery to remove the ovaries before they develop cancer. Methods. Women who had undergone prophylactic oophorectomy (surgical group; n=30) were compared with women who remained on the ovarian screening program (nonsurgical group; n=28) on their importance ratings for a number of relevant decision-making factors. Results. The most important decision-making factor across all subjects was reducing risk of ovarian cancer, but the single best predictor of group membership was the importance attributed to reducing cancer worry. Women who rated this factor as more important were more likely to be in the surgical group. No women identified the increased risk of heart disease and osteoporosis as issues for consideration. Conclusions. The desire to reduce cancer worry is likely to be the most important factor in a woman's decision to proceed to prophylactic oophorectomy. In view of the current imprecision in risk estimates given to women considering this option, cancer worry may override a more rational consideration of the costs and benefits of surgery. (C) 2001 American Health Foundation and Elsevier Science.
引用
收藏
页码:578 / 585
页数:8
相关论文
共 22 条
[1]   CANCER PREVENTION IN PRIMARY-CARE - SCREENING FOR OVARIAN, PROSTATIC, AND TESTICULAR CANCERS .8. [J].
AUSTOKER, J .
BRITISH MEDICAL JOURNAL, 1994, 309 (6950) :315-320
[2]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[3]   Genetic susceptibility testing and prophylactic oophorectomy [J].
Berchuck, A ;
Carney, ME ;
Futreal, PA .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 82 (02) :159-164
[4]   The genetics of ovarian cancer. An assessment of current screening protocols and recommendations for counseling families at risk [J].
Bombard, AT ;
Fields, AL ;
Aufox, S ;
BenYishay, M .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1996, 39 (04) :860-872
[5]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[6]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[7]   RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].
FORD, D ;
EASTON, DF ;
BISHOP, DT ;
NAROD, SA ;
GOLDGAR, DE ;
HAITES, N ;
MILNER, B ;
ALLAN, L ;
PONDER, BAJ ;
PETO, J ;
SMITH, S ;
STRATTON, M ;
LENOIR, GM ;
FEUNTEUN, J ;
LYNCH, H ;
ARASON, A ;
BARKARDOTTIR, R ;
EGILSSON, V ;
BLACK, DM ;
KELSELL, D ;
SPURR, N ;
DEVILEE, P ;
CORNELISSE, CJ ;
VARSEN, H ;
BIRCH, JM ;
SKOLNICK, M ;
SANTIBANEZKOREF, MS ;
TEARE, D ;
STEEL, M ;
PORTER, D ;
COHEN, BB ;
CAROTHERS, A ;
SMYTH, E ;
WEBER, B ;
NEWBOLD, B ;
BOEHNKE, M ;
COLLINS, FS ;
CANNONALBRIGHT, LA ;
GOLDGAR, D .
LANCET, 1994, 343 (8899) :692-695
[8]  
FRY A, IN PRESS PSYCHOONCOL
[9]  
Hallowell N, 2000, PSYCHO-ONCOL, V9, P486, DOI 10.1002/1099-1611(200011/12)9:6<486::AID-PON478>3.3.CO
[10]  
2-P